Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Helix Exploration says production from flagship project 'imminent'

(Sharecast News) - Montana-focused helium development company Helix Exploration said it has acquired an additional well at the Rudyard Field as it continues to target first helium production this summer. The company announced on Wednesday that it has a binding letter of intent to buy an additional production well (Weil #1) and 640-acre leasehold from Global Helium for £230,000 in cash.

Meanwhile, a drilling contract has been signed for the Linda #1, located just one mile south from Helix's successful Darwin #1 well, which is awaiting the construction of a helium processing plant. Linda #1 will cost $1.3m to drill and complete, is expected to generate $4m per year in pre-tax cash flow.

"We are now starting a highly active phase for the company with the imminent production of helium at Rudyard this summer," said chief executive Bo Sears.

"We will be drilling at Linda #1 next month and have agreed to acquire the Weil #1 well on favourable terms, saving the company over a million dollars by acquiring a production ready well."

Shares were down 2.5% at 13.80p by 1329 GMT.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.